PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,900,000 | -96.3% | 9,400 | -98.6% | 0.10% | -97.9% |
| Q3 2017 | $78,781,000 | +165.9% | 657,876 | +94.1% | 4.97% | +178.9% |
| Q2 2017 | $29,628,000 | +818.7% | 338,994 | +291.0% | 1.78% | +682.0% |
| Q1 2017 | $3,225,000 | -92.2% | 86,700 | -78.4% | 0.23% | -80.6% |
| Q4 2013 | $41,550,000 | +132.7% | 401,330 | +20.6% | 1.17% | +162.1% |
| Q3 2013 | $17,858,000 | -45.9% | 332,791 | -55.3% | 0.45% | -42.0% |
| Q2 2013 | $33,029,000 | – | 744,403 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,400,000 | $25,032,000 | 1.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,365,376 | $14,241,000 | 1.38% |
| Palo Alto Investors LP | 1,343,897 | $14,017,000 | 0.84% |
| Sofinnova Investments, Inc. | 1,197,630 | $12,491,000 | 0.79% |
| Gyon Technologies Capital Management, LP | 29,745 | $310,000 | 0.75% |
| RICE HALL JAMES & ASSOCIATES, LLC | 455,567 | $4,752,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 63,226 | $659,000 | 0.17% |
| PDT Partners, LLC | 188,538 | $1,966,000 | 0.13% |
| CADENCE CAPITAL MANAGEMENT LLC | 71,179 | $742,000 | 0.11% |
| FRED ALGER MANAGEMENT, LLC | 2,474,029 | $25,804,000 | 0.08% |